BrainSpec Gets FDA Clearance of AI-Backed Solution for Brain Chemistry Measurement
BrainSpec was awarded FDA clearance to begin using its MRS platform for non-invasive measurement of brain chemistry.
Read MorePosted by Andy Lundin | Nov 27, 2023 | Dementias & Alzheimer’s |
BrainSpec was awarded FDA clearance to begin using its MRS platform for non-invasive measurement of brain chemistry.
Read MorePosted by Chris Wolski | Nov 22, 2023 | Disease States |
Metabolic dysfunction-associated steatotic liver disease is estimated to affect about 32.4% of the world’s population.
Read MorePosted by Andy Lundin | Nov 21, 2023 | Womens Health |
Machine learning algorithms designed to diagnose a common infection that affects women showed a diagnostic bias among ethnic groups.
Read MorePosted by Chris Wolski | Nov 16, 2023 | Diagnostic Technologies |
Consolidation, legislation, new testing types, and a shift to more consumer-driven testing are some clinical laboratory predictions for 2024.
Read MorePosted by Andy Lundin | Nov 16, 2023 | Sexually Transmitted Diseases |
The FDA granted marketing authorization to a diagnostic test for chlamydia and gonorrhea with at-home sample collection.
Read More